Phase I/II Study of erlotinib combined with cisplatin and radiotherapy in patients with locallyadvanced squamous cell carcinoma of the head and neck

Herchenhorn, Daniel; Dias, Fernando L; Viegas, C‚la M. P; Federico, Miriam H; Ara£jo, Carlos Manoel M; Small, Isabelle; Bezerra, Marcos; FontÆo, Karina; Knust, Renata E; Ferreira, Carlos Gil Moreira; Martins, Renato G.
Int J Radiat Oncol Biol Phys ; 78(3): 696-702, 1 nov.2010. graf
Artículo en Inglés | TXTC | ID: txt-23698

Documentos relacionados

  1. Innovative radiation oncology Together - Precise, Personalized, Human : Vision 2030 for radiotherapy & radiation oncology in Germany.
  2. From Basic Radiobiology to Translational Radiotherapy.
  3. A Qualitative Analysis of Medical Student Reflections Following Participation in a Canadian Radiation Oncology Studentship.
  4. Digital transfer in radiation oncology education for medical students-single-center data and systemic review of the literature.
  5. ACVR and ECVDI consensus statement: Reporting elements for toxicity criteria of the veterinary radiation therapy oncology group v2.0.
  6. Human factor associations with safety events in radiation therapy.
  7. A national repository of complete radiotherapy plans: design, Results, and experiences.
  8. A Novel USMLE® Step 1 Based Approach to Introducing Radiation Oncology to Second-Year Preclinical Medical Students.
  9. Radiotherapy trial quality assurance processes: a systematic review.
  10. "Per protocol" practice patterns for Children's Oncology Group trials within the radiation oncology community.